Durable Medical Equipment on Lien: How Pharmacy Fills the Medication Gap

James Wong — Founder & Pharmacist, LienScripts | July 25, 2025 | 8 min read

Durable medical equipment — cervical collars, lumbar braces, TENS units, knee braces — is among the most common lien-based care in personal injury cases. But DME treats the structural problem while medications treat the pain and inflammation. A pharmacy lien alongside DME coverage creates a comprehensive treatment record that documents both dimensions of injury.

DME Is the Most Common Lien-Based Provider in PI Cases

Walk through the file of virtually any motor vehicle accident case and you'll find a durable medical equipment provider. Cervical collars after rear-end collisions. Lumbar supports after back injuries. Knee braces after accidents involving leg impact. TENS units for pain management between appointments. Wrist splints, shoulder slings, and ankle supports for the full range of orthopedic injuries that result from vehicle accidents.

DME providers operate on lien for the same reason every other lien-based care provider does: injured patients cannot wait for insurance resolution to access the medical equipment they need to function. A patient with a lumbar compression fracture cannot wait six months for a back brace. A patient with cervical spine instability cannot wait for insurance authorization for a soft collar. DME on lien fills the gap immediately.

What DME cannot provide is pharmacological treatment. Equipment stabilizes, supports, and offloads. Medications manage pain, suppress inflammation, relax muscle spasm, and address the neurological dimensions of injury — nerve pain, anxiety, sleep disruption — that equipment cannot reach. The two categories of treatment are complementary, not substitutes for each other.

[!KEY] A pharmacy lien alongside DME coverage creates a two-source documentation record — the DME provider determined the patient needed external support, and an independent prescriber determined the same injury required ongoing pharmacological management — two practitioners, two independent clinical determinations, one coherent injury narrative.

What DME Actually Covers

Durable medical equipment is a broad category. In personal injury cases, the most common items include:

Orthotics and Supports

Cervical collars and neck braces are standard in rear-end collision cases with cervical strain. They limit range of motion during the acute inflammatory phase and provide proprioceptive support to the healing cervical musculature. Lumbar supports and back braces serve a similar function for low back injuries — reducing load on the lumbar spine during activities of daily living while the patient is under active treatment.

Knee braces are common in accident cases involving lower extremity injury, particularly where ligament strain or meniscal injury is present. Wrist splints and shoulder braces address upper extremity injuries from bracing during impact.

TENS Units

Transcutaneous electrical nerve stimulation units are frequently dispensed on lien for patients with chronic pain between treatment visits. They provide non-pharmacological pain relief that the patient can self-administer at home — useful as an adjunct to medication management rather than a replacement for it.

Mobility Equipment

Crutches, walkers, and canes are dispensed when lower extremity injury impairs the patient's ability to ambulate safely. These are typically short-duration items used during the acute recovery phase following fracture or significant soft tissue injury.

[!KEY] Enrolling a patient in a pharmacy lien at the same time as DME enrollment captures the acute-phase medication record — the period when prescription needs are highest and the documentation of injury severity is most valuable to the case.

The Medication Gap That DME Doesn't Fill

A back brace provides lumbar support. It does not reduce the inflammation in the lumbar facet joints, suppress the painful muscle spasm in the paraspinal musculature, or address the nerve pain that radiates into the lower extremities when disc herniation is present.

A cervical collar limits motion. It does not manage the pain of cervical strain, reduce the inflammatory response in the soft tissue, or address the sleep disruption that consistently high pain levels produce.

This is the medication gap: the pharmacological dimension of injury management that requires prescription intervention from a licensed prescriber, dispensed through a pharmacy, taken consistently between treatment visits and physical therapy sessions.

The medications commonly prescribed in conjunction with DME use include:

• Cyclobenzaprine and methocarbamol for muscle spasm — directly addressing the hypertonicity that often accompanies orthopedic injury
• Meloxicam and other NSAIDs for the inflammatory component — particularly important during the acute and subacute phases when tissue inflammation is highest
• Gabapentin for nerve pain when imaging reveals disc pathology or when radicular symptoms are present
• Topical agents including diclofenac gel for localized pain management at the brace or support site
• Sleep aids when pain disruption is impairing the nighttime rest necessary for tissue healing

A pharmacy lien runs concurrently with DME coverage and captures the prescription record that DME alone cannot document.

[!NOTE] A cervical collar limits motion but cannot manage pain or inflammation — a pharmacy lien covers the prescriptions that address the pharmacological dimensions of injury that DME, by design, cannot reach.

How DME and Pharmacy Records Work Together at Settlement

In soft tissue and orthopedic PI cases, defense counsel's standard arguments include that the treatment was excessive, the duration was disproportionate to the mechanism, and the objective findings don't support the claimed injury severity. Comprehensive multi-provider records are the most effective counter to these arguments.

The DME record establishes that a prescribing physician determined the patient required external support or assistance devices — which is itself documentation of injury severity. The pharmacy record establishes that the same or a different treating physician separately determined that ongoing prescription-level pharmacological management was necessary.

Two independent practitioners. Two independent determinations of clinical need. Both documented in contemporaneous records over the same treatment period. That convergence of independent documentation is harder to minimize than a single provider's file.

The MERIT report that LienScripts provides at settlement includes the complete dispensing history, medication details, and the documentation attorneys need to establish the pharmacy lien amount in the settlement.

Setting Up Pharmacy Coverage Alongside DME

DME providers typically cannot prescribe medications — their scope is equipment dispensing. The pharmacy lien runs through a separate prescribing physician who is managing the patient's pharmacological care: often the urgent care or ER physician who initiated treatment, the patient's primary care provider, or a specialist such as an orthopedist or pain management physician.

Once prescriptions are in place, enrollment through LienScripts is straightforward. Visit how it works for the enrollment process or for attorneys to understand the documentation and settlement process.

The practical point: the sooner pharmacy coverage is established after DME enrollment, the more complete the pharmacy record will be. Early enrollment captures the acute phase medication record — the time when prescription needs are highest and the documentation of severity is most valuable.

For attorneys building a comprehensive lien-based care plan that includes DME, adding pharmacy lien coverage is a straightforward addition that strengthens the overall treatment record without creating additional complexity at settlement.

[!KEY] When defense counsel argues the injury was minor based on the DME list alone, a concurrent pharmacy record showing gabapentin for nerve pain and cyclobenzaprine for spasm reflects an independent prescriber's clinical determination that the injury required ongoing pharmacological management — not just mechanical support.